Lv1
86 积分 2025-05-21 加入
Process Development of the Novel LpxC Inhibitor T‑1228. Part 4: Control of Mutagenic Impurities during API Synthesis
1个月前
已完结
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies
2个月前
已完结
Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control
2个月前
已完结
Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines
3个月前
已完结
Workflows for Quality Risk Management of Nitrosamine Risks in Medicines
3个月前
已完结
Analytical Characterization of Biotherapeutics
6个月前
已完结
Method Validation in Pharmaceutical Analysis
6个月前
已完结
Genotoxic Impurities
1年前
已完结
Genotoxic Impurities
1年前
已关闭
Genotoxic Impurities
1年前
已关闭